Pfizer’s CEO said he was “fairly certain” that the vaccine the company is developing in partnership with BioNTech SE is safe and could be made available to Americans before 202.
2 min read
The United States will likely have a COVID-19 vaccine available to the public before the end of the year and the company is prepared for that scenario, said Albert Bourla, Pfizer CEO.
Bourla noted on CBS’s “Face the Nation” Sunday that he was “fairly certain” that the vaccine the company is developing in partnership with BioNTech SE is safe and that it could be made available to Americans, depending on 2021, ever having received approvals from the Food and Drug Administration (FDA).
“I can’t tell what the FDA is going to do,” said Bourla. “But I think that’s a likely scenario and we are preparing for it,” reported Bloomberg.
These statements differ from other less enthusiastic expectations of health authorities. New York-based Pfizer and German company BioNTech, along with Moderna and AstraZeneca Plc, are considered leaders in the race to develop a coronavirus vaccine. Bourla says there is a 60% chance that Pfizer and its partner will know the effectiveness of their still experimental vaccine by the end of October.
“Of course that doesn’t mean that it works. That means we’ll know if it works, ”said Bourla. The date the clinical trial results will be available depends on enough people taking the trial and receiving COVID-19 for the math. However, positive results could pave the way for approval, he said.